Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Assessing the Utility of In Vitro Screening Tools for Predicting Bio-Performance of Oral Peptide Delivery.

Gadgil P, Alleyne C, Feng KI, Hu M, Gindy M, Buevich AV, Fauty S, Salituro G, Wen J, Li Y, Nofsinger R, Sawyer TK, Buist N.

Pharm Res. 2019 Aug 26;36(10):151. doi: 10.1007/s11095-019-2682-8.

PMID:
31451949
2.

Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy.

van den Berg MMGA, Kok DE, Posthuma L, Kamps L, Kelfkens CS, Buist N, Geenen M, Haringhuizen A, Heijns JB, van Lieshout RHMA, Los M, Sommeijer DW, Timmer-Bonte JNH, de Kruif ATCM, van Laarhoven HWM, Kampman E, Winkels RM.

Breast Cancer Res Treat. 2019 Jan;173(2):475-481. doi: 10.1007/s10549-018-5014-5. Epub 2018 Oct 23.

3.

Taste and smell perception and quality of life during and after systemic therapy for breast cancer.

de Vries YC, Boesveldt S, Kelfkens CS, Posthuma EE, van den Berg MMGA, de Kruif JTCM, Haringhuizen A, Sommeijer DW, Buist N, Grosfeld S, de Graaf C, van Laarhoven HWM, Kampman E, Winkels RM.

Breast Cancer Res Treat. 2018 Jul;170(1):27-34. doi: 10.1007/s10549-018-4720-3. Epub 2018 Feb 23.

4.

Impacting Global Health Through Equipment Repurposing: Measurable Progress Through the Accumulation of Many Tiny Victories.

Buist NL, Minnihan EC, Young K, Yang L.

J Pharm Sci. 2018 Mar;107(3):788-793. doi: 10.1016/j.xphs.2017.10.016. Epub 2017 Oct 24.

PMID:
29074379
5.

Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyrase.

Walker SS, Labroli M, Painter RE, Wiltsie J, Sherborne B, Murgolo N, Sher X, Mann P, Zuck P, Garlisi CG, Su J, Kargman S, Xiao L, Scapin G, Salowe S, Devito K, Sheth P, Buist N, Tan CM, Black TA, Roemer T.

PLoS One. 2017 Jul 10;12(7):e0180965. doi: 10.1371/journal.pone.0180965. eCollection 2017.

6.

Differences in dietary intake during chemotherapy in breast cancer patients compared to women without cancer.

de Vries YC, van den Berg MMGA, de Vries JHM, Boesveldt S, de Kruif JTCM, Buist N, Haringhuizen A, Los M, Sommeijer DW, Timmer-Bonte JHN, van Laarhoven HWM, Visser M, Kampman E, Winkels RM.

Support Care Cancer. 2017 Aug;25(8):2581-2591. doi: 10.1007/s00520-017-3668-x. Epub 2017 Mar 16.

7.

Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes.

Guo L, Parker DL, Zang Y, Sweis RF, Liu W, Sherer EC, Buist N, Terebetski J, Kelly T, Bugianesi R, Priest BT, Dingley KH, Li X, Mitelman S, Salituro G, Trujillo ME, Pachanski M, Kirkland M, Powles MA, Eiermann GJ, Feng Y, Shang J, Howard AD, Ujjainwalla F, Sinz CJ, Debenham JS, Edmondson SD, Nargund RP, Hagmann WK, Li D.

ACS Med Chem Lett. 2016 Oct 12;7(12):1107-1111. eCollection 2016 Dec 8.

8.

Historical Perspective on Clinical Trials of Carnitine in Children and Adults.

Buist NR.

Ann Nutr Metab. 2016;68 Suppl 3:1-4. Epub 2016 Dec 9. Review.

9.

Round Table Discussion.

Winter S, Buist NR, Longo N, Armenian SH, Lopaschuk G, Wasilewska A.

Ann Nutr Metab. 2016;68 Suppl 3:21-23. Epub 2016 Dec 9.

10.

Artificial intelligence in medicine: humans need not apply?

Diprose W, Buist N.

N Z Med J. 2016 May 6;129(1434):73-6.

PMID:
27349266
11.

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor.

Neelamkavil SF, Agrawal S, Bara T, Bennett C, Bhat S, Biswas D, Brockunier L, Buist N, Burnette D, Cartwright M, Chackalamannil S, Chase R, Chelliah M, Chen A, Clasby M, Colandrea VJ, Davies IW, Eagen K, Guo Z, Han Y, Howe J, Jayne C, Josien H, Kargman S, Marcantonio K, Miao S, Miller R, Nolting A, Pinto P, Rajagopalan M, Ruck RT, Shah U, Soriano A, Sperbeck D, Velazquez F, Wu J, Xia Y, Venkatraman S.

ACS Med Chem Lett. 2015 Dec 22;7(1):111-6. doi: 10.1021/acsmedchemlett.5b00425. eCollection 2016 Jan 14.

12.

Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [(11)C]MK-8193.

Hostetler ED, Fan H, Joshi AD, Zeng Z, Eng W, Gantert L, Holahan M, Meng X, Miller P, O'Malley S, Purcell M, Riffel K, Salinas C, Williams M, Ma B, Buist N, Smith SM, Coleman PJ, Cox CD, Flores BA, Raheem IT, Cook JJ, Evelhoch JL.

Mol Imaging Biol. 2016 Aug;18(4):579-87. doi: 10.1007/s11307-015-0910-0.

PMID:
26596571
13.

Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.

Hoyt SB, Petrilli W, London C, Liang GB, Tata J, Hu Q, Yin L, van Koppen CJ, Hartmann RW, Struthers M, Wisniewski T, Ren N, Bopp C, Sok A, Cai TQ, Stribling S, Pai LY, Ma X, Metzger J, Verras A, McMasters D, Chen Q, Tung E, Tang W, Salituro G, Buist N, Clemas J, Zhou G, Gibson J, Maxwell CA, Lassman M, McLaughlin T, Castro-Perez J, Szeto D, Forrest G, Hajdu R, Rosenbach M, Xiong Y.

ACS Med Chem Lett. 2015 Jul 17;6(8):861-5. doi: 10.1021/acsmedchemlett.5b00048. eCollection 2015 Aug 13.

14.

Fever and elevated CRP-related to clozapine dose.

Buist NC, Schauer CK.

Aust N Z J Psychiatry. 2016 Feb;50(2):182-3. doi: 10.1177/0004867415590629. Epub 2015 Jun 18. No abstract available.

PMID:
26089534
15.

Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.

Hoyt SB, Park MK, London C, Xiong Y, Tata J, Bennett DJ, Cooke A, Cai J, Carswell E, Robinson J, MacLean J, Brown L, Belshaw S, Clarkson TR, Liu K, Liang GB, Struthers M, Cully D, Wisniewski T, Ren N, Bopp C, Sok A, Cai TQ, Stribling S, Pai LY, Ma X, Metzger J, Verras A, McMasters D, Chen Q, Tung E, Tang W, Salituro G, Buist N, Kuethe J, Rivera N, Clemas J, Zhou G, Gibson J, Maxwell CA, Lassman M, McLaughlin T, Castro-Perez J, Szeto D, Forrest G, Hajdu R, Rosenbach M, Ali A.

ACS Med Chem Lett. 2015 Apr 7;6(5):573-8. doi: 10.1021/acsmedchemlett.5b00054. eCollection 2015 May 14.

16.

TMEM165 deficiency causes a congenital disorder of glycosylation.

Foulquier F, Amyere M, Jaeken J, Zeevaert R, Schollen E, Race V, Bammens R, Morelle W, Rosnoblet C, Legrand D, Demaegd D, Buist N, Cheillan D, Guffon N, Morsomme P, Annaert W, Freeze HH, Van Schaftingen E, Vikkula M, Matthijs G.

Am J Hum Genet. 2012 Jul 13;91(1):15-26. doi: 10.1016/j.ajhg.2012.05.002. Epub 2012 Jun 7.

17.

Quantification of intraoral pressures during nutritive sucking: methods with normal infants.

Lang WC, Buist NR, Geary A, Buckley S, Adams E, Jones AC, Gorsek S, Winter SC, Tran H, Rogers BR.

Dysphagia. 2011 Sep;26(3):277-86. doi: 10.1007/s00455-010-9305-1. Epub 2010 Sep 19.

PMID:
20853119
18.

IDH2 mutations in patients with D-2-hydroxyglutaric aciduria.

Kranendijk M, Struys EA, van Schaftingen E, Gibson KM, Kanhai WA, van der Knaap MS, Amiel J, Buist NR, Das AM, de Klerk JB, Feigenbaum AS, Grange DK, Hofstede FC, Holme E, Kirk EP, Korman SH, Morava E, Morris A, Smeitink J, Sukhai RN, Vallance H, Jakobs C, Salomons GS.

Science. 2010 Oct 15;330(6002):336. doi: 10.1126/science.1192632. Epub 2010 Sep 16.

19.

Discussants made misleading statements about seizures.

Buist NR.

Pediatr Ann. 2009 Jul;38(7):352-3. No abstract available.

PMID:
19688880
20.

Scene from the USA: the illogic of mandating screening without also providing for treatment.

Buist NR, Huntington K.

J Inherit Metab Dis. 2007 Aug;30(4):445-6. No abstract available.

PMID:
17805992
21.

S-adenosylhomocysteine hydrolase deficiency in a 26-year-old man.

Buist NR, Glenn B, Vugrek O, Wagner C, Stabler S, Allen RH, Pogribny I, Schulze A, Zeisel SH, Barić I, Mudd SH.

J Inherit Metab Dis. 2006 Aug;29(4):538-45. Epub 2006 May 30.

22.

Contrasting phenotypes in three patients with novel mutations in mitochondrial tRNA genes.

Anitori R, Manning K, Quan F, Weleber RG, Buist NR, Shoubridge EA, Kennaway NG.

Mol Genet Metab. 2005 Feb;84(2):176-88. Epub 2004 Dec 15.

PMID:
15670724
23.

Two adult galactosaemia females with normal ovarian function and identical GALT mutations (Q188R/R333G).

Ng WG, Xu YK, Wong LJ, Kaufman FR, Buist NR, Donnell GN.

J Inherit Metab Dis. 2003;26(1):75-9.

PMID:
12872845
24.

Metabolic evaluation of infantile epilepsy: summary recommendations of the Amalfi Group.

Buist NR, Dulac O, Bottiglieri T, Gärtner J, Rinaldo P, Wolf NI; Amalfi Group.

J Child Neurol. 2002 Dec;17 Suppl 3:3S98-102.

PMID:
12597059
25.

Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins.

Enns GM, Steiner RD, Buist N, Cowan C, Leppig KA, McCracken MF, Westphal V, Freeze HH, O'brien JF, Jaeken J, Matthijs G, Behera S, Hudgins L.

J Pediatr. 2002 Nov;141(5):695-700.

PMID:
12410200
26.

Experience of working in an Afghan camp.

Buist NR.

BMJ. 2002 Oct 19;325(7369):S127. No abstract available.

PMID:
12386062
27.

Height and cataract.

Buist NR.

Am J Clin Nutr. 2002 Jan;75(1):162. No abstract available.

PMID:
11756074
28.

Warfarin therapy does not increase bleeding in patients undergoing heart transplantation.

Morris CD, Vega JD, Levy JH, Buist NN, Smith AL, Despotis GJ, Kanter KR.

Ann Thorac Surg. 2001 Sep;72(3):714-8.

PMID:
11565646
29.

Newborn screening (NBS). Everyone screens for something! Pitfalls for the unwary!

Buist NR.

Southeast Asian J Trop Med Public Health. 1999;30 Suppl 2:45-6. No abstract available.

PMID:
11400778
30.

Hepatic carnitine palmitoyl transferase 1 (CPT1 A) deficiency in North American Hutterites (Canadian and American): evidence for a founder effect and results of a pilot study on a DNA-based newborn screening program.

Prasad C, Johnson JP, Bonnefont JP, Dilling LA, Innes AM, Haworth JC, Beischel L, Thuillier L, Prip-Buus C, Singal R, Thompson JR, Prasad AN, Buist N, Greenberg CR.

Mol Genet Metab. 2001 May;73(1):55-63.

PMID:
11350183
31.

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME.

Nat Genet. 2001 Jan;27(1):18-20.

PMID:
11137992
32.

Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene.

Keightley JA, Anitori R, Burton MD, Quan F, Buist NR, Kennaway NG.

Am J Hum Genet. 2000 Dec;67(6):1400-10. Epub 2000 Oct 20.

33.

Novel mutations in 13 probands with galactokinase deficiency.

Kolosha V, Anoia E, de Cespedes C, Gitzelmann R, Shih L, Casco T, Saborio M, Trejos R, Buist N, Tedesco T, Skach W, Mitelmann O, Ledee D, Huang K, Stambolian D.

Hum Mutat. 2000;15(5):447-53.

PMID:
10790206
34.

Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine.

Winter SC, Buist NR.

Am Heart J. 2000 Feb;139(2 Pt 3):S63-9. Review.

PMID:
10650319
35.

Folinic acid-responsive neonatal seizures.

Torres OA, Miller VS, Buist NM, Hyland K.

J Child Neurol. 1999 Aug;14(8):529-32.

PMID:
10456764
36.

Undiagnosed maternal phenylketonuria: the need for prenatal selective screening or case finding.

Hanley WB, Platt LD, Bachman RP, Buist N, Geraghty MT, Isaacs J, O'Flynn ME, Rhead WJ, Seidlitz G, Tishler B.

Am J Obstet Gynecol. 1999 Apr;180(4):986-94. Review.

PMID:
10203668
37.

HELLP syndrome.

Buist NR, Winter SC.

JAMA. 1999 Feb 24;281(8):704-5. No abstract available.

PMID:
10052438
38.

D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity?

van der Knaap MS, Jakobs C, Hoffmann GF, Nyhan WL, Renier WO, Smeitink JA, Catsman-Berrevoets CE, Hjalmarson O, Vallance H, Sugita K, Bowe CM, Herrin JT, Craigen WJ, Buist NR, Brookfield DS, Chalmers RA.

Ann Neurol. 1999 Jan;45(1):111-9.

PMID:
9894884
39.

Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0.

Orho M, Bosshard NU, Buist NR, Gitzelmann R, Aynsley-Green A, Blümel P, Gannon MC, Nuttall FQ, Groop LC.

J Clin Invest. 1998 Aug 1;102(3):507-15.

40.

Inborn errors of metabolism: medical and administrative "orphans".

Winter SC, Buist NR.

Am J Manag Care. 1998 Aug;4(8):1164-8.

41.

Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations.

Wexler ID, Hemalatha SG, McConnell J, Buist NR, Dahl HH, Berry SA, Cederbaum SD, Patel MS, Kerr DS.

Neurology. 1997 Dec;49(6):1655-61.

PMID:
9409363
42.

Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping.

Neufeld EJ, Mandel H, Raz T, Szargel R, Yandava CN, Stagg A, Fauré S, Barrett T, Buist N, Cohen N.

Am J Hum Genet. 1997 Dec;61(6):1335-41.

44.

Molecular analysis of the beta-glucuronidase gene: novel mutations in mucopolysaccharidosis type VII and heterogeneity of the polyadenylation region.

Vervoort R, Buist NR, Kleijer WJ, Wevers R, Fryns JP, Liebaers I, Lissens W.

Hum Genet. 1997 Apr;99(4):462-8.

PMID:
9099834
45.

Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.

Heath H 3rd, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano IV, Garrett JE, Leppert MF.

J Clin Endocrinol Metab. 1996 Apr;81(4):1312-7.

PMID:
8636323
46.

A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria.

Keightley JA, Hoffbuhr KC, Burton MD, Salas VM, Johnston WS, Penn AM, Buist NR, Kennaway NG.

Nat Genet. 1996 Apr;12(4):410-6.

PMID:
8630495
47.

A woman with bone pain, fractures, and malabsorption.

Buist NR.

Lancet. 1996 Mar 23;347(9004):829. No abstract available.

PMID:
8622355
48.

Early copper therapy in classic Menkes disease patients with a novel splicing mutation.

Kaler SG, Buist NR, Holmes CS, Goldstein DS, Miller RC, Gahl WA.

Ann Neurol. 1995 Dec;38(6):921-8.

PMID:
8526465
49.

Isolated persistent hypermethioninemia.

Mudd SH, Levy HL, Tangerman A, Boujet C, Buist N, Davidson-Mundt A, Hudgins L, Oyanagi K, Nagao M, Wilson WG.

Am J Hum Genet. 1995 Oct;57(4):882-92.

50.

A clinical approach to inborn errors of metabolism.

Buist NR.

Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:100-8.

PMID:
8629085

Supplemental Content

Support Center